Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1ICD-10 adaptations of the Ontario acute myocardial infarction mortality prediction rules performed as well as the original versions2007 · 62 citations
2. 2Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes2013 · 168 citations
3. 3Factors Associated With Age Disparities Among Cancer Clinical Trial Participants2019 · 230 citations
4. 4First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.2021 · 38 citations
5. 5Diabetes in Ontario2002 · 1,291 citations